Genetron Holdings (NASDAQ:GTH) reported quarterly losses of $(0.37) per share. This is a 184.62 percent decrease over losses of $(0.13) per share from the same period last year.
Earnings Outlook For VistaGen Therapeutics
VistaGen Therapeutics (NASDAQ:VTGN) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement.
Analysts estimate that VistaGen Therapeutics will report an earnings per share (EPS) of $-0.07.